rs727503040

Variant summary

Our verdict is Likely benign.
-1 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -1 classification points (ACGS-UK Somatic Oncogenicity v2025). B3_Supporting

The NM_001379180.1(ESRRB):c.460+4C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The gene ESRRB is a tumor suppressor gene (CancerMine: 2 TSG, 2 driver citations). The gene ESRRB is a cancer driver gene (CancerMine: 2 TSG, 2 driver citations). The variant allele was found at a cumulative frequency of 0.0000219 (AC=32) in the gnomAD database across 1,460,138 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000341. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★). The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000022 ( 0 hom. )

Consequence

ESRRB
NM_001379180.1 splice_region, intron

Scores

3
Splicing: ADA: 0.002958
2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.398

Publications

0 publications found
Variant links:
Genes affected
ESRRB (HGNC:3473): (estrogen related receptor beta) This gene encodes a protein with similarity to the estrogen receptor. Its function is unknown; however, a similar protein in mouse plays an essential role in placental development. [provided by RefSeq, Jul 2008]
ESRRB Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 35
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001379180.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -1 points.

B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Splice-region variant — splicing algorithms predict no impact on splicing; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001379180.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ESRRB NM_001379180.1
MANE Select
HGVSc / HGVSpc.460+4C>T
Exon rankIntron 2 of 6
splice_regionintron
Prot: NP_001366109.1UniProt: A0A2R8Y491
ESRRB NM_004452.4
HGVSc / HGVSpc.397+4C>T
Exon rankIntron 4 of 10
splice_regionintron
Prot: NP_004443.3
ESRRB NM_001411038.1
HGVSc / HGVSpc.412+4C>T
Exon rankIntron 2 of 6
splice_regionintron
Prot: NP_001397967.1UniProt: E7EWD9

Ensembl Transcripts

ESRRB ENST00000644823.1
MANE Select
HGVSc / HGVSpc.460+4C>T
Exon rankIntron 2 of 6
splice_regionintron
Prot: ENSP00000493776.1UniProt: A0A2R8Y491
ESRRB ENST00000509242.5
TSL:1
HGVSc / HGVSpc.397+4C>T
Exon rankIntron 2 of 8
splice_regionintron
Prot: ENSP00000422488.1UniProt: O95718-1
ESRRB ENST00000505752.6
TSL:1
HGVSc / HGVSpn.397+4C>T
Exon rankIntron 4 of 11
splice_regionintron
Prot: ENSP00000423004.1UniProt: O95718-2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
Cov:33
GnomAD2 exomes
AF: 0.0000361
AC:9
AN:249550
GnomAD4 exome
AF: 0.0000219
AC:32
Hom:0
AN:1460138
Cov:36
GnomAD4 genome
Cov:33
TOPMed (Bravo)
AF: 0.0000302
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000774
AC:2
Hom:0
AN:25828
Local & regional cohorts 1 source
Turkish Variome
AF: 0.000358
AC:2
Hom:0
AN:5106
Showing 7 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.00 028420 0.0000347 128844
SCHEMA
(Schizophrenia)
0.0000691 7101310 0.0000717 13181314
Showing 2 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)

Computational Scores

AlphaGenome AVI
Benign1.7
BayesDel_noAF
Benign-0.41
CADD
Benign16
DANN
Benign0.85
GPN-Star LLR
N/A-2.7
GPN-Star score
N/A2.7
PhyloP100
Benign-0.40
PromoterAI
N/A-0.078Neutral
Showing 8 of 8 scores

Splicing Scores

dbscSNV1_ADA
Benign0.0030
dbscSNV1_RF
Benign0.038
Pangolin (max)
Benign0.020
SpliceAI score (max)
Benign0.020
Details are displayed if max score is > 0.2
Showing 4 of 4 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.